Literature DB >> 18396539

[Evaluation of sperm mitochondrial membrane potential by JC-1 fluorescent staining and flow cytometry].

Xin-Yi Xia1, Yong-Ming Wu, Bao-Shan Hou, Bin Yang, Lian-Jun Pan, Yi-Chao Shi, Bao-Fang Jin, Yong Shao, Ying-Xi Cui, Yu-Feng Huang.   

Abstract

OBJECTIVE: To investigate the feasibility and clinical significance of detecting sperm mitochondrial membrane potential (MMP) by JC-1 fluorescent staining and flow cytometry, and to explore the relationship between the results of JC-1 staining and seminal parameters.
METHODS: Sixty-three semen samples were divided into a fertile (n = 31) and an infertile group (n = 32) and underwent computer-assisted semen analysis (CASA). All the samples were washed, followed by JC-1 staining and evaluation of sperm MMP by flow cytometry. The percentage of normal sperm MMP was indicated as the percentage of sperm emitting orange-red fluorescence (JC-1 + %).
RESULTS: The JC-1 + % was significantly higher in the fertile group than in the infertile one ([75.89 +/- 15.69]% vs [54.04 +/- 22.21] %, P = 0.000), correlated positively with sperm motility (r = 0.610, P = 0.000) and the percentage of grade a + b sperm (r = 0.614, P = 0.000) and negatively with grade d sperm (r = -0.504, P = 0.000). There was a significant positive correlation between the results of JC-1 staining (JC-1 + %) and that of Rh123 /PI dual fluorescent staining (Rh123 + / PI (-)%) (r = 0.938, P = 0.000).
CONCLUSION: JC-1 staining and flow cytometry could readily and quickly detect sperm MMP and the sperm JC-1 + % could be an auxiliary marker for the diagnosis of male infertility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396539

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  1 in total

1.  Effect of Polygonatum odoratum extract on human breast cancer MDA-MB-231 cell proliferation and apoptosis.

Authors:  Yu Tai; Yi-Ming Sun; Xue Zou; Qiong Pan; Ya-Dong Lan; Qiang Huo; Jing-Wen Zhu; Fei Guo; Chang-Quan Zheng; Cheng-Zhu Wu; Hao Liu
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.